Kamada Ltd. (KMDA)
NASDAQ: KMDA · Real-Time Price · USD
8.34
-0.02 (-0.24%)
Apr 23, 2026, 12:57 PM EDT - Market open
Kamada Revenue
In the year 2025, Kamada had annual revenue of $180.46M with 12.12% growth. Kamada had revenue of $44.68M in the quarter ending December 31, 2025, with 14.54% growth.
Revenue (ttm)
$180.46M
Revenue Growth
+12.12%
P/S Ratio
2.65
Revenue / Employee
$390,606
Employees
462
Market Cap
477.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 180.46M | 19.51M | 12.12% |
| Dec 31, 2024 | 160.95M | 18.43M | 12.93% |
| Dec 31, 2023 | 142.52M | 13.18M | 10.19% |
| Dec 31, 2022 | 129.34M | 25.70M | 24.79% |
| Dec 31, 2021 | 103.64M | -29.60M | -22.22% |
| Dec 31, 2020 | 133.25M | 6.06M | 4.76% |
| Dec 31, 2019 | 127.19M | 12.72M | 11.11% |
| Dec 31, 2018 | 114.47M | 11.64M | 11.32% |
| Dec 31, 2017 | 102.83M | 25.33M | 32.69% |
| Dec 31, 2016 | 77.49M | 7.59M | 10.85% |
| Dec 31, 2015 | 69.91M | -1.16M | -1.63% |
| Dec 31, 2014 | 71.07M | 442.00K | 0.63% |
| Dec 31, 2013 | 70.62M | -2.05M | -2.82% |
| Dec 31, 2012 | 72.68M | 13.19M | 22.18% |
| Dec 31, 2011 | 59.48M | 25.01M | 72.53% |
| Dec 31, 2010 | 34.48M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tilray Brands | 858.28M |
| Emergent BioSolutions | 742.90M |
| Organogenesis Holdings | 564.17M |
| Esperion Therapeutics | 403.14M |
| Evolus | 297.18M |
| Ironwood Pharmaceuticals | 296.15M |
| Akebia Therapeutics | 236.20M |
| Canopy Growth | 203.04M |
KMDA News
- 13 days ago - Significant Move: Lilach Payorski Invests $80K In Kamada Stock Options - Benzinga
- 13 days ago - Eran Nir Sees Potential Growth And Acquires $178K In Kamada Stock Options - Benzinga
- 13 days ago - David Tsur Takes A Bullish Stance, Acquiring $113K Worth Of Kamada Stock Options - Benzinga
- 13 days ago - Ishay Davidi Expands Holdings With $113K Kamada Stock Options Acquisition - Benzinga
- 13 days ago - Chaime Orlev At Kamada Secures Company Stock Options: $417K Acquired - Benzinga
- 13 days ago - Nir Livneh Enhances Portfolio With Kamada Stock Options: $206K Acquired - Benzinga
- 13 days ago - Benjamin Dekel Takes A Bullish Stance, Acquiring Kamada Stock Options Worth $41K - Benzinga
- 13 days ago - Leon Recanati Expands Holdings With $115K Kamada Stock Options Acquisition - Benzinga